Novel strategies to target lung cancer metastasis to bone
Novel strategies to target lung cancer metastasis to bone
批准号:
10646351
负责人:
GEORGE R. BECK
金额:
$17.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-15 至 2025-05-31
关键词:
A549AdenocarcinomaAdenocarcinoma In SituAllelesAntibodiesBehaviorBreastCalciumCancer Cell GrowthCancer ControlCancer EtiologyCancer PatientCause of DeathCell LineCell SurvivalCellsClinicalComplexConsumptionDataDiagnosisDietDietary InterventionDiseaseDisseminated Malignant NeoplasmElementsEnvironmentEtiologyEventFailureFemoral FracturesFractureFrequenciesGenetically Engineered MouseGrowthHomingHyperplasiaImageImmune systemIncidenceIntakeKRASG12DKnowledgeLinkLoxP-flanked alleleLuciferasesLungLung AdenocarcinomaMalignant NeoplasmsMalignant neoplasm of lungMetastatic Neoplasm to the BoneMethodologyMicroscopyMineralsModalityModelingMonitorMusNeoplasm MetastasisNutritionalOsteoporosisPainPharmaceutical PreparationsPhenotypePhosphotransferasesPhysiologicalPre-Clinical ModelPrevalencePreventionPrevention approachProcessPrognosisProstateRecoveryRegulationResolutionRisk FactorsSerumSiteSkeletonSoilTNFSF11 geneTestingTherapeuticTherapeutic StudiesTransgenic MiceTropismTumor PromotionTumor Suppressor ProteinsXenograft Modelbisphosphonatebonebone imagingbone lossbone metabolismbone turnovercancer cellcancer diagnosiscancer preventioncell behaviorcellular imagingcomorbiditydraining lymph nodedrug repurposingfracture riskhuman migrationimaging modalityin vivoinnovationinorganic phosphateinsightlanthanum carbonatelifestyle factorsmetastatic processmicroCTmouse modelneoplastic cellnovelnovel anticancer drugnovel strategiesnovel therapeutic interventionnutritionosteopontinpain reductionpharmacologicpre-clinicalpreventrelease factorsensorside effectskeletaltherapeutic targetthree dimensional cell culturetumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Metastasis is the leading cause of death from cancer. Metastasis to bone represents a particularly poor
prognosis. Unfortunately, the skeleton is one of the most common sites of metastasis for cancers such as
breast, prostate and lung. Further, metastasis to bone results in significant pain, loss of mobility and increased
fractures, among other comorbidities. The underlying mechanisms are incompletely understood and treatment
options are mostly limited to attempting to reduce pain and fracture risk after diagnosis. Therefore, an
enhanced understanding of the underlying etiology and/or a novel strategy to prevent or reduce bone
metastasis would represent a significant advance to a field sorely in need of new options. One major obstacle
to understanding, as well as developing therapeutic options for bone metastases is the paucity of pre-clinical
models that faithfully recapitulate this multi-stage complex process. We have identified a novel genetically
engineered mouse model in which to study lung cancer progression and metastasis to bone. Further, we
believe we have identified a novel risk factor for cancer cell growth and survival as well as a factor that strongly
influences the bone microenvironment in inorganic phosphate (Pi). Studies proposed herein will probe at the
underlying mechanisms of bone metastasis combining a state-of-the-art mouse metastasis model, advanced
microscopy and micro-computed tomography in the context of a novel and highly translational nutrition based
prevention approach. Specifically, we will test the hypothesis that: The KrasG12D; Lkb1fl/fl; Rosa-luciferase
mouse represents a model of spontaneous lung cancer metastasis to bone. Further, that this model can be
used to study therapeutic and prevention modalities as well as provide mechanistic insight into this complex
disease. To test this hypothesis we will: 1) therapeutically target spontaneous metastasis to bone using the
KLLlenti mouse model, and 2) determine if differences in Pi transport drive a bone seeking phenotype. Impact:
Results from the current proposal have the potential to provide new information about the mechanisms by
which a common nutritional element might be manipulated to alter cell behavior related to cancer etiology as
well as a better understanding of the skeletal environment which promotes tumor cell establishment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel strategies to target lung cancer metastasis to bone
-
批准号:10513138
-
项目类别:
-
资助金额:$21.95万
-
财政年份:2022
-
负责人:GEORGE R. BECK
-
依托单位:
ShEEP Request For A Pre-Clinical In-Vivo X-Ray Micro Computed-Tomography Scanner
-
批准号:10178581
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:GEORGE R. BECK
-
依托单位:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
-
批准号:9280823
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:GEORGE R. BECK
-
依托单位:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
-
批准号:8974367
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:GEORGE R. BECK
-
依托单位:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
-
批准号:8634211
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:GEORGE R. BECK
-
依托单位:
Contribution of Phosphate to Inflammatory Bone Loss
-
批准号:10588936
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:GEORGE R. BECK
-
依托单位:
Inorganic phosphate regulated proliferation, transformation and tumorigenesis
-
批准号:8444660
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2010
-
负责人:GEORGE R. BECK
-
依托单位:
Inorganic phosphate regulated proliferation, transformation and tumorigenesis
-
批准号:7889954
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2010
-
负责人:GEORGE R. BECK
-
依托单位:
Inorganic phosphate regulated proliferation, transformation and tumorigenesis
-
批准号:8076343
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2010
-
负责人:GEORGE R. BECK
-
依托单位:
Inorganic phosphate regulated proliferation, transformation and tumorigenesis
-
批准号:8240098
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2010
-
负责人:GEORGE R. BECK
-
依托单位:
Dietary Inorganic Phosphate as a Target for Nutritional intervention in Cancer
-
批准号:7896743
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2009
-
负责人:GEORGE R. BECK
-
依托单位:
Dietary Inorganic Phosphate as a Target for Nutritional intervention in Cancer
-
批准号:7753114
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2009
-
负责人:GEORGE R. BECK
-
依托单位:
Biological Actions and Cellular Targeting of Nanoparticles for Medical Applicatio
-
批准号:7883443
-
项目类别:
-
资助金额:$28.17万
-
财政年份:2008
-
负责人:GEORGE R. BECK
-
依托单位:
Biological Actions and Cellular Targeting of Nanoparticles for Medical Applicatio
-
批准号:7454848
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2008
-
负责人:GEORGE R. BECK
-
依托单位:
Biological Actions and Cellular Targeting of Nanoparticles for Medical Applicatio
-
批准号:7649321
-
项目类别:
-
资助金额:$32.76万
-
财政年份:2008
-
负责人:GEORGE R. BECK
-
依托单位:
ROLE OF P270 IN DIFFERENTIATION AND TUMORIGENESIS
-
批准号:6052019
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2005
-
负责人:GEORGE R. BECK
-
依托单位:
ROLE OF P270 IN DIFFERENTIATION AND TUMORIGENESIS
-
批准号:7116483
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2005
-
负责人:GEORGE R. BECK
-
依托单位:
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
-
批准号:30840003
-
项目类别:专项基金项目
-
资助金额:12.0万元
-
批准年份:2008
-
负责人:焦宇飞
-
依托单位: